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The Chicken Yolk Sac IgY Receptor, a Functional
Equivalent of the Mammalian MHC-Related Fc
Receptor, Is a Phospholipase A2 Receptor Homolog
class I MHC light chain (Simister and Mostov, 1989).
The crystal structures of the ectodomains of rat FcRn
(Burmeister et al., 1994a) and human FcRn (West and
Bjorkman, 2000) confirm the structural similarity with
class I MHC molecules predicted by the sequences, but
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MHC molecules for presentation of antigenic peptides
to T cells is narrowed and nonfunctional. The signifi-
cance of the structural similarity with MHC moleculesSummary
is unclear as FcRn binds to IgG using residues from
the side of its counterpart of the MHC peptide bindingIn mammals, IgG is transferred from mother to young
domain and from 2-microglobulin (Martin et al., 2001)by the MHC-related receptor FcRn, which binds IgG
in an interaction that bears no resemblance to MHCin acidic endosomes and releases it at basic pH into
interactions with peptides or macromolecules.blood. Maternal IgY, the avian counterpart of IgG, is
Biochemical studies of membrane-bound and solubletransferred to embryos across yolk sac membranes.
forms of FcRn demonstrate that IgG binding is pH de-We affinity-purified the chicken yolk sac IgY receptor
pendent: there is strong binding (nanomolar KD) under(FcRY) and sequenced its gene. FcRY is unrelated to
the acidic conditions (pH 6.0) found in endosomalMHC molecules but is a homolog of the mammalian
compartments and in rodent intestines, while at thephospholipase A2 receptor. Analytical ultracentrifuga-
slightly basic pH of blood (pH 7.4), there is no detectabletion and truncation experiments suggest that FcRY
binding (Ghetie and Ward, 2000). From mutagenesis andforms a compact structure containing an IgY binding
crystallographic studies, the mechanism of this pH de-site at acidic pH but undergoes a conformational
pendence has been revealed to involve chemical ratherchange at basic pH that disrupts the site. FcRY is thus
than conformational changes (Kim et al., 1994; Martinunrelated to mammalian FcRn in both its structure
et al., 2001; Vaughn and Bjorkman, 1998). Specifically,and mechanism for pH-dependent binding, illustrating
there are attractive interactions at acidic pH betweendistinct routes utilized by evolution to transfer anti-
protonated histidines on Fc and negatively charged sidebodies.
chains on FcRn, which are lost upon deprotonation of
the Fc histidines at basic pH (Martin et al., 2001). The
Introduction sequences of FcRn genes isolated from other organ-
isms, including pig (Schnulle and Hurley, 2003), sheep
Acquired immunity in the form of immunoglobulin is (Mayer et al., 2002), macaque (GenBank accession num-
passed from mother to young in many vertebrate spe- ber AAL92101), brushtail possum (Adamski et al., 2000),
cies (Brambell, 1970). In mammals, this occurs in utero and cow (Kacskovics et al., 2000), suggest that the fea-
(as for humans) or after birth through ingested milk (as tures described above for rodent and human FcRn pro-
for rodents). In both cases, immunoglobulin G (IgG) is teins are shared in the other mammalian orthologs.
transported across a cellular barrier via transcytosis by Transfer of passive immunity to offspring is not con-
the neonatal Fc receptor (FcRn), a receptor specific for fined to mammals. In birds and some reptiles, immuno-
the Fc portion of IgG (Ghetie and Ward, 2000). The first globulin Y (the avian/reptilian counterpart of IgG) is
FcRn proteins and genes to be characterized were from packaged in the yolk compartment of eggs. During late
rodents, where FcRn is expressed in the neonatal small embryonic development, IgY is transported across the
intestine (Simister and Mostov, 1989), the fetal yolk sac yolk sac membrane into the embryonic bloodstream
(Roberts et al., 1990), mammary gland (Cianga et al., (Kowalczyk et al., 1985). Chicken yolk sac membranes
1999), liver, vascular endothelium (Borvak et al., 1998), contain an IgY binding activity with characteristics simi-
and respiratory epithelium (Spiekermann et al., 2002). lar to mammalian FcRn (nanomolar binding at pH 6, no
In humans, because of a different organization of extra- binding at pH 8) (Linden and Roth, 1978; Tressler and
embryonic membranes, the placental syncytiotropho- Roth, 1987), but the protein responsible for pH-depen-
blast rather than the yolk sac is the major site of FcRn- dent binding of IgY had not been isolated or character-
mediated maternal immunoglobulin transport (Leach et ized. Here we report the isolation, cloning, and charac-
al., 1996; Simister et al., 1996). terization of the chicken yolk sac membrane IgY
Mammalian FcRn is a heterodimer with two polypep- receptor, which we have named FcRY. The receptor is
tide chains: a membrane-bound heavy chain sharing a 1459 residue protein that is unrelated to mammalian
FcRn. Instead, FcRY appears to be the avian homolog22%–29% sequence identity in its extracellular domains
of the secretory phospholipase A2 receptor (PLA2R) (Fig-with class I MHC molecules and a noncovalently attached
ure 1). Like PLA2R, the FcRY ectodomain contains anlight chain, 2-microglobulin, which also serves as the
N-terminal cysteine-rich (CysR) domain, a fibronectin
type II (FNII) repeat, and eight C-type lectin-like domains*Correspondence: bjorkman@caltech.edu
(CTLDs). Binding studies using isolated FcRY fragments3Present address: Department of Molecular Genetics, Biochemistry,
reveal that IgY binding requires regions from the firstand Microbiology, University of Cincinnati College of Medicine, Cin-
cinnati, Ohio 45267. two domains and the CTLDs, which interact with each
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Figure 1. Schematic Representations of the
Structures of the MHC-Related Mammalian
FcRn, a Class I MHC Molecule, Chicken Yolk
Sac IgY Receptor FcRY (red), and Mannose
Receptor Family Members
Sequence identities between FcRY and other
mannose receptor (MR) family members are
based on pairwise alignments to human MR
family proteins.
other at acidic pH to form a pH-dependent IgY binding bands in the molecular weight range corresponding to
mammalian FcRn (35 to 53 kDa) or 2-microglobulinsite. These results are used to propose a conformational
change model for pH-dependent recognition of IgY and (11 kDa). The sequence of a proteolytic fragment of
FcRY matched two overlapping chicken ESTs (Board-to discuss the evolution of Fc receptor function and the
MHC fold. man et al., 2002), allowing a full-length cDNA clone to
be obtained by rapid amplification of cDNA Ends
(RACE) PCR.Results
The 5499 bp FcRY cDNA clone encodes a predicted
type I transmembrane protein of 1459 amino acidsPurification and Cloning of FcRY
To isolate the protein responsible for the pH-dependent that shares 55% amino acid sequence identity with
the human secretory phospholipase A2 receptor (PLA2R),IgY binding activity from chicken yolk sacs, we adapted
the protocol used to purify mammalian FcRn from rat a member of the mannose receptor (MR) family (Fig-
ure 1 and see Supplemental Figure S1 at http://www.fetal yolk sacs (Roberts et al., 1990). Yolk sacs from day
18–19 chick embryos were solubilized in detergent and immunity.com/cgi/content/full/20/5/601/DC1). Cloning
of an avian PLA2R has not been reported previously,passed over an IgY affinity column at pH 6. After elution
of the column at pH 8, a single major band migrating and a BLAST search of chicken ESTs and genomic DNA
indicates that FcRY is the closest avian homolog ofwith an apparent molecular weight of 180 kDa was ob-
served by SDS-PAGE (Figure 2A). There were no visible PLA2R (data not shown). FcRY and all mammalian
Figure 2. Affinity-Purified FcRY and FcRY Expression Pattern
(A) Coomassie-stained 12% SDS-PAGE of affinity-purified FcRY. The sample was derived from solubilized chicken yolk sac membranes that
were passed over an IgY affinity column at pH 6 and eluted at pH 8.
(B) Northern blot analysis of FcRY expression in chicken tissues. The RNA blot was probed with a 695 bp 32P-dATP-labeled PCR-generated
FcRY probe.
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PLA2Rs share a common domain architecture with other affinity binding sites (corresponding to doubly and singly
ligated IgY molecules, respectively), yielding a high affin-members of the MR family: an N-terminal signal se-
quence followed by a cysteine-rich domain, a single ity KD of 12 nM and a low affinity KD of 1 M for
IgY binding to immobilized FcRY. These values can befibronectin type II domain, eight to ten C-type lectin-like
domains, a transmembrane domain, and a cytoplasmic directly compared to earlier binding studies using yolk
sac membranes, in which the macroscopic or apparenttail containing 40 residues (Figure 1). In common with
mammalian PLA2Rs, the FcRY cytoplasmic domain in- KD values for IgY binding were derived as 15 nM and
340 nM for the high- and low-affinity binding sites (Tres-cludes two potential endocytosis motifs: a dihydropho-
bic sequence (EESILI, matching an ExxxØØ motif com- sler and Roth, 1987).
The ligand binding specificity of FcRY was tested bymon to the MR family, where Ø is a bulky hydrophobic
amino acid) and an altered tyrosine-based motif injecting other potential ligands over an FcRY-coupled
chip at pH 6.0. Little or no binding was observed for(WVRNAYF versus the consensus tyrosine-based motif
ØxNxxY) (East and Isacke, 2002). human IgG (a mixture of IgG1, 2, 3, and 4), human IgE,
rat Fc (derived from rat IgG1), or porcine pancreaticTo determine whether FcRY is expressed in locations
other than the yolk sac membrane, an RNA blot of adult PLA2. In experiments conducted at pH 7.4, no binding
was observed for human Fc or mouse IgG (data notchicken tissues was probed with a gene-specific probe
(Figure 2B). A strong band corresponding to an 6.5 shown).
To verify the 2:1 FcRY-IgY stoichiometry suggestedkb transcript was observed in liver, ovary, oviduct, and
spleen. Lower levels of expression were observed in by the binding studies, we examined mixtures of FcRY
and FcY under binding conditions (pH 6.0) by sedimenta-most tissues except the brain and cecum. FcRY expres-
sion in tissues besides the yolk sac membrane may tion velocity analytical ultracentrifugation (AUC) (Figure
3D). Under conditions in which 1:1 complex formationreflect a role protecting IgY from catabolism, similar to
FcRn’s function extending the serum half-life of IgG in is favored (an FcRY:FcY molar ratio of 1:25), we observe
a species sedimenting at 9.7 S. A 1:1 molar ratio ofmammals (Ghetie and Ward, 2000).
FcRY:FcY contains species sedimenting at several dif-
ferent rates; these likely correspond to small amountsFcRY Binds IgY with Nanomolar Affinity
of free FcY, 1:1, and 2:1 complexes. A 2:1 mixture ofat Acidic, but Not Basic, pH
FcRY:FcY resulted in species sedimenting at 13 S,To verify that the FcRY gene encodes a functional IgY
consistent with a 2:1 stoichiometry of FcRY:FcY. Differ-receptor, full-length FcRY was expressed in Chinese
ential sedimentation of species in dynamic equilibriumhamster ovary (CHO) cells. FcRY-expressing CHO cells
causes the 1:1 and 2:1 samples to be shifted and broadershow cell surface staining when incubated with Cy3-
than theoretical nondissociating complexes. A global fitlabeled FcY (Fc fragment of IgY) at pH 6 but not at pH
of data collected at three molar ratios (2:1, 1:1, 1:25),8 (Supplemental Figure S2), demonstrating that FcRY is
yielded affinity constants for the binding of the first anda type I membrane protein expressed at the cell surface,
second FcRY molecules to FcY (KD1  110 nM, KD2 as predicted from its sequence, and that the FcRY cDNA
280 nM) consistent with those obtained from the SPRencodes the previously described pH-dependent IgY
analysis.binding activity of chicken yolk sac membranes (Tressler
and Roth, 1987).
To derive quantitative binding data for the FcRY-IgY Multiple Domains of FcRY Are Required
for IgY Bindinginteraction, we examined the binding of FcY and IgY to
a recombinant soluble FcRY ectodomain expressed in In order to localize the IgY binding site on FcRY, we
expressed truncated forms of FcRY: CysR alone, CysR-baculovirus-infected insect cells using a surface plas-
mon resonance (SPR)-based binding assay. FcRY was FNII, CysR-FnII-CTLD1-4, CTLD1-8, and CysR-FNII-
CTLD5-8 (Figure 4A). The FcRY fragments were purifiedcovalently coupled to the surface of a biosensor chip,
and IgY or FcY was injected at pH 6, pH 7.4, or pH 8. and tested for binding of IgY in an SPR-based binding
assay as described above. None of the fragmentsBinding experiments were also conducted in the reverse
orientation by injecting FcRY over immobilized IgY or showed significant binding of IgY (data not shown).
However, a mixture of the CysR-FNII fragment and theFcY. In both cases, significant binding of IgY and FcY
was observed at pH 6 but not at pH 8 or 7.4 (Figures CTLD1-8 fragment binds IgY at pH 6 (Figure 4B). No
binding was observed at pH 8 between IgY and the3A–3C). The binding was unaffected by the presence or
absence of calcium (10 mM calcium acetate) or EDTA CysR-FNII and CTLD1-8 mixture (Figure 4B); thus, the
pH-dependent binding between FcRY and IgY is pre-(5 mM) (data not shown). To derive equilibrium binding
affinities, the pH 6 data were fit to models assuming a served when the FcRY ectodomain is fragmented. To
further explore the mechanism of IgY binding using1:1 or a 2:1 FcRY:FcY interaction. A bivalent model that
describes the sequential binding of two FcRY molecules FcRY fragments, we tested for binding between the
CysR-FNII and CTLD1-8 fragments. In an SPR-basedto an FcY homodimer fits the data better than a 1:1
model, yielding affinities of 140–220 nM (KD1) and 230– assay in which the CysR-FNII fragment was immobilized
on a biosensor chip, CTLD1-8 bound at pH 6 but showed1600 nM (KD2) for the first and second binding events
(Figures 3A and 3B). For binding of IgY, the sequential no detectable binding at pH 8 (Figure 4C). These results
suggest that FcRY forms an IgY binding structure at pHbinding affinities are 99 nM (KD1) and 2.8 M (KD2) (data
not shown). As an alternative to this stepwise (micro- 6 in which the CysR-FNII region folds back upon the
CTLD1-8 region and that disruption of this conformationscopic) binding model, the binding can also be de-
scribed macroscopically as a mixture of high and low at pH 8 prevents IgY binding (Figure 4D).
Immunity
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Figure 3. Surface Plasmon Resonance (A–C) and AUC (D) Analyses of the FcRY-FcY Interaction at pH 6
(A) Biosensor data for experiments in which FcY was injected over FcRY immobilized at three different densities: 500, 2400, and 7700 RU.
The equilibrium binding response (Req) is plotted versus the log of the concentration of injected protein. Best-fit binding curves, derived from
a bivalent analyte binding model, are superimposed on the binding data. When the same binding data are analyzed assuming a heterogeneous
ligand model, in which the coupled population of molecules is assumed to contain two independent classes of binding sites, we derive a high
affinity KD of 4 nM (49% of population) and a low affinity KD of 1.3 M (51% of population).
(B) Representative sensorgrams (colored lines) derived from injection of different concentrations of FcRY over immobilized FcY. Three hundred
and seventy RU of FcY was immobilized. Kinetic data were fit globally using a bivalent ligand model (black lines).
(C) Sensorgrams demonstrating that immobilized FcRY (3620 RU) binds IgY at pH 6 but not at pH 7.4.
(D) Sedimentation velocity AUC analysis of FcRY:FcY mixtures. The sedimentation coefficient distribution was determined for FcRY and FcY
alone and for mixtures containing 1:1, 2:1, and 1:25 molar ratios of FcRY:FcY. The arrows indicate the approximate molecular weights and
calculated sedimentation coefficients (derived from SedAnal) of free FcY, free FcRY, and 1:1 and 2:1 FcRY:FcY complexes. These s* values
describe how these species would sediment if not in equilibrium with each other.
FcRY Undergoes a pH-Dependent Conformational sequence of the FcRY ectodomain predicts ten tandem
domains, hence a potentially extended structure. Con-Change that Correlates with IgY Binding
To explore the possibility of a pH-dependent conforma- sistent with this prediction, velocity AUC data obtained
at pH 8 (Figure 5B) yielded a sedimentation coefficienttional change in FcRY, we examined its behavior on a
gel filtration column. We find that the FcRY ectodomain (s*) of 7.21  0.01 S and an f/f0 value (the ratio of the
experimental frictional coefficient to that of an ideal non-migrates with the characteristics of an extended protein
on a gel filtration column at pH 8, eluting earlier than hydrated sphere) of 1.78. By comparison, typical f/f0
values for globular proteins range from 1.2 to 1.4 (Tan-IgG, which has a similar molecular mass. By contrast,
at pH 6, the FcRY ectodomain elutes later from the ford, 1961). The values obtained for FcRY at pH 8 are
similar to those reported for the MR ectodomain at pHcolumn, consistent with a more compact conformation
(Figure 5A). 7.8 (s020,w7.290.02 S; f/f01.63) (Napper et al., 2001).
In contrast to the monomeric and extended structureTo further investigate the possibility of a pH-depen-
dent conformational change in FcRY, we used sedimen- predicted for the FcRY ectodomain at basic pH, velocity
AUC studies of FcRY at pH 6 suggest a more compacttation velocity AUC, a technique that provides informa-
tion on the size and shape of proteins in solution. The structure with an s* value of 7.91  0.03 S and f/f0 
The Chicken Yolk Sac IgY Receptor
605
Figure 4. FcRY Deletion Constructs and Their IgY Binding Properties
(A) Schematic representation of soluble FcRY constructs, containing either the entire FcRY ectodomain or fragments thereof, and their IgY
binding properties. Fragments listed as not binding to IgY showed no detectable binding to IgY at concentrations up to 5 M (data not shown).
(B) Sensorgrams obtained in biosensor experiments by injecting IgY at pH 6 over immobilized FcRY fragments. CysR-FNII and CTLD1-8 were
immobilized individually (red and green) or together (blue). IgY binding occurs only in the flow cell containing both CysR-FNII and CTLD1-8.
The quantities immobilized were 4950 RU of CysR-FNIICTLD1-8, 1680 RU of CysR-FNII, and 5840 RU of CTLD1-8.
(C) Sensorgrams demonstrating that CTLD1-8 binds to immobilized CysR-FNII (1220 RU) at pH 6 but not at pH 8.
(D) Model of pH-dependent conformational change of FcRY. FcRY has an extended conformation at pH 8 (s*  7.2 S) with no predicted
interaction between the CysR-FNII domains and the CTLDs. At pH 6 the CysR-FNII region folds back and binds to the CTLDs, resulting in a
more compact conformation (s*  7.9 S) that is able to bind IgY. The site on the CTLD1-8 region where the CysR-FNII domains bind is not
known; hence, the figure is schematic and shows one possibility.
1.38 (derived from a 30 nM sample of FcRY). A potential derived from experiments conducted with low concen-
trations of FcRY.complication for interpretation of these results is that
the sedimentation velocity AUC data derived from FcRY Oligomerization of the MR has also been observed by
AUC but was calcium dependent and suggested to re-samples at concentrations greater than 160 nM revealed
multiple species (Figure 5B). A global fit of velocity AUC sult from oligosaccharides on one receptor binding to
the carbohydrate recognition domain on another recep-data for all FcRY concentrations at pH 6 suggested that
FcRY dimerizes with a KD of 6.4M (Experimental Proce- tor (Napper et al., 2001). A similar mechanism is not
likely for FcRY because FcRY dimerization is calciumdures).
To confirm the velocity AUC results, equilibrium AUC independent and because the FcRY CTLDs lack resi-
dues found in functional carbohydrate recognition do-experiments were performed with varying FcRY concen-
trations at pH 6 and 8 (Supplemental Experimental Pro- mains (see Discussion and Supplemental Figure S1). An
alternative mechanism for FcRY dimerization, which iscedures and Supplemental Figure S3). At pH 8, the FcRY
equilibrium AUC data reveal a single species with a consistent with observation of dimers at acidic pH only
and with the interaction between the CysR-FNII andmolecular mass of170 kDa. In contrast, the pH 6 equi-
librium AUC data can best be fit to a dimerization model CTLD1-8 fragments at pH 6, is formation of a domain-
swapped dimer in which the CysR-FNII region of onewith a calculated KD for dimerization of 4.6 M (Supple-
mental Experimental Procedures and Supplemental Fig- FcRY molecule binds to the CTLDs of another.
ure S3), consistent with the dimerization KD calculated
from the pH 6 sedimentation velocity AUC data. At low Discussion
FcRY concentrations (30–50 nM) at pH 6, FcRY sedi-
ments as a single species in both velocity and equilib- Here we report cloning, heterologous expression, and
binding studies of an avian Fc receptor present on therium AUC experiments; thus, dimerization at pH 6 is not
responsible for the pH-dependent difference in s* values chicken yolk sac membrane. Previous studies identified
Immunity
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Figure 5. Biophysical Evidence of a pH-Dependent Conformational Change of FcRY
(A) Analytical gel filtration elution profiles of FcRY and IgG at pH 6 and pH 8. FcRY, but not IgG, shows a pH-dependent difference in its
elution profile. Both FcRY samples were injected at 800 nM.
(B) Sedimentation velocity AUC of FcRY samples at pH 6 and pH 8. The sedimentation coefficient distribution was determined at several
FcRY concentrations. Peak heights were normalized. The pH 8 data collected at 640 nM and 320 nM FcRY yielded sedimentation coefficient
distributions essentially identical to the 160 nM curve. At pH 6, the samples of FcRY at higher concentrations have sedimentation distributions
indicating partial FcRY dimerization. The lower concentration pH 6 curves converge to a single species with an s* value of 7.9 S.
a pH-dependent IgY binding activity in yolk sac mem- but not mammalian IgGs. Finally, FcRY belongs to the
MR family, a group of proteins that characteristicallybranes (Linden and Roth, 1978; Tressler and Roth, 1987).
This binding activity was hypothesized to be responsible endocytose bound ligands (East and Isacke, 2002), and
the FcRY cytoplasmic tail contains a consensus endocy-for transfer of maternal antibodies to newborn chicks
for the following reasons: (1) IgY transport from yolk to tosis motif.
There are two steps in the transfer of immunity fromchick is specific, thereby requiring a receptor (Brambell,
1970); (2) the site of IgY transport from yolk to embryo hen to chick. In the first step, antibodies are loaded into
the yolk compartment of the developing oocyte. FcRY,is the yolk sac membrane (Brambell, 1970), and (3) the
IgY binding protein on the yolk sac membrane has the which does not bind human IgG, does not appear to be
involved in this process, as it has been shown that hu-same pH-dependent binding as FcRn, the mammalian
functional equivalent (Tressler and Roth, 1987; Ghetie man IgGs are transported into chicken egg yolk (Mo-
hammed et al., 1998; Morrison et al., 2002). Instead, ourand Ward, 2000). This pH-dependent binding would per-
mit the IgY binding protein to transfer maternal IgY from data suggest that FcRY is the receptor responsible for
the second step in transferring antibodies from yolkegg yolk (pH 6) to the embryonic circulation (pH 7.4),
just as rodent intestinal FcRn transports maternal IgG to the embryonic circulation, as mammalian antibodies
injected into yolk sacs are not transferred to newlyfrom ingested milk to the neonatal bloodstream (Ghetie
and Ward, 2000). hatched chicks (Brambell, 1970).
Despite similarities in function and binding properties,We used a functional purification procedure involving
an IgY affinity column to isolate a pH-dependent IgY FcRY and mammalian FcRn are not related in sequence
or domain organization. Instead FcRY is the chickenbinding protein from chicken yolk sac membranes. The
resulting protein, which we have named FcRY, binds to counterpart of the mammalian M (muscle)-type PLA2
receptor, which binds and endocytoses secretory PLA2the IgY column at pH 6 and is eluted from the column
at pH 8. No other yolk sac proteins were observed upon as part of a signal transduction pathway (Hanasaki and
Arita, 1999). PLA2R is a member of the MR family ofelution of the IgY column at pH 8. After isolating the
FcRY cDNA, we expressed recombinant FcRY proteins proteins, which are type I membrane proteins character-
ized by an ectodomain containing an N-terminal cys-in transfected cells and as a soluble ectodomain frag-
ment and demonstrated that FcRY binds to IgY with teine-rich domain, a fibronectin II repeat, and 8–10
CTLDs (East and Isacke, 2002). Although no transcytosisnanomolar affinity at pH 6 and exhibits no significant
binding at pH 7.4 or pH 8. This magnitude of a pH- functions have been ascribed to other MR family mem-
bers, they contain endocytic sequence motifs in theirdependent affinity transition near neutral pH is a rare
property shared by few other proteins besides FcRn, cytoplasmic domains and perform endocytic roles, recy-
cling between the plasma membrane and endosomalarguing that the ability to bind ligand at the acidic pH
of intracellular vesicles and release ligand at the basic compartments (East and Isacke, 2002). One of the best-
characterized members of the family, MR, binds carbo-pH of blood is critical for the function of FcRY. Further
evidence supporting the identification of FcRY as the hydrates on foreign and host molecules. Two portions
of MR bind carbohydrates: two of the CTLDs function asreceptor responsible for IgY transport is that FcRY ex-
hibits the same immunoglobulin binding specificity as carbohydrate recognition domains to mediate calcium-
dependent recognition of terminal mannose, fucose,previously described for the IgY transporter (Brambell,
1970; Warr et al., 1995): namely, it binds FcY and IgY, and N-acetylglucosamine carbohydrates that are com-
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monly found on microorganisms, and the cysteine-rich that cannot bind IgY. Interestingly, studies of the MR and
Endo180 ectodomains also demonstrate an interactiondomain of mannose receptor (Cys-MR) binds to glyco-
proteins containing sulfated sugars (Fiete and Baen- between the CysR-FNII and CTLD portions of these re-
ceptors: protease digestion experiments indicate thatziger, 1997; Fiete et al., 1998). In addition to MR and
PLA2R, other members of the MR family include the MR CysR and FNII interact with CTLD1-2 (Napper et al.,
2001), and an electron microscopy structure of Endo180dendritic cell receptor DEC-205, which is believed to
capture extracellular antigens and direct their transport shows an interaction between CysR and CTLD2 (Rivera-
Calzada et al., 2003).to an antigen-processing compartment (Jiang et al.,
1995), and Endo180, which plays a role in remodeling Regarding the FcRY binding site on IgY, our binding
studies demonstrate that FcRY binds to FcY and intactthe extracellular matrix (East and Isacke, 2002).
The presence of two potential carbohydrate binding IgY with comparable affinities; thus, FcRY specifically
recognizes the Fc region of IgY with little or no contribu-regions within FcRY raises the question of whether FcRY
functions as a lectin. The cysteine-rich domain of FcRY tion to binding from the IgY Fab arms. The Fc region of
IgY, like mammalian IgE and IgM molecules, containsis unlikely to recognize sulfated sugars because its se-
quence, like those of other MR family members except three constant domains (CH2, CH3, CH4), as compared
with mammalian IgG Fc regions, which contain two (CH2,for MR itself, shows alterations in the region known
from the crystal structure of a Cys-MR/4-sulfated-N- CH3). N-terminal sequencing of the FcY used for the
binding experiments revealed that it starts at the CH3acetylgalactosamine complex (Liu et al., 2000) to inter-
act with sulfated sugars (see Supplemental Figure S1 domain (data not shown); thus, the FcRY binding site
on FcY can be localized to the CH3-CH4 region of IgY.at http://www.immunity.com/cgi/content/full/20/5/601/
DC1). In addition, the presence of CTLDs within the Likewise, FcRI binds to the CH3-CH4 region of the IgE
Fc fragment, with no involvement of the CH2 domainsFcRY sequence does not guarantee carbohydrate bind-
ing, as most of the CTLDs in MR family members do (Garman et al., 2000). However, unlike the FcRI or the
FcR receptors, which bind to their immunoglobulin li-not exhibit C-type lectin activity (East and Isacke, 2002).
The FcRY and PLA2R CTLDs lack calcium-coordinating gands in an asymmetric interaction with a 1:1 receptor/
ligand stoichiometry (Garman et al., 2000; Sondermannresidues that are critical for calcium-dependent carbo-
hydrate recognition in true carbohydrate recognition do- et al., 2000), two FcRY molecules bind to each IgY or
FcY molecule, implying a symmetric interaction in whichmains (Weis et al., 1998) (Supplemental Figure S1); thus,
FcRY and the PLA2Rs are not predicted to function as one FcRY binds to each chain of the FcY dimer analo-
gous to recognition of IgG by mammalian FcRn (Bur-calcium-dependent lectins. Indeed, mammalian PLA2Rs
bind nonglycosylated forms of PLA2 (Lambeau et al., meister et al., 1994b). In the case of the FcRn-Fc interac-
tion, titration of a patch of histidines at the bend between1994). Likewise, we propose that FcRY binds IgY by a
protein-protein interaction, consistent with the observa- the Fc CH2 and CH3 domains (H310, H435, H436 in rat
IgG) is responsible for a chemical change that mediatestion that FcRY binding to IgY is unaffected by the pres-
ence of EDTA or calcium (data not shown). Carbohydrate the pH dependence of the FcRn:IgG interaction (Martin
et al., 2001). Counterpart histidines are not found in IgYrecognition in some contexts cannot be completely
ruled out, however. For example, PLA2R shows non- (Parvari et al., 1988); thus, the pH dependence of the
FcRY-IgY interaction cannot be ascribed to an analo-calcium-dependent binding to a mannose conjugate of
bovine serum albumin (Lambeau et al., 1994; Nicolas et gous chemical change, providing a possible rationaliza-
tion of the conformational change mechanism proposedal., 1995). A high mannose oligosaccharide is attached
to the single N-linked glycosylation site of FcY (Suzuki for the pH dependence of the FcRY:IgY interaction.
To our knowledge FcRY is the first chicken Fc receptorand Lee, 2004); thus, carbohydrate recognition could
play a role in FcY binding by FcRY. However, the require- to be purified and molecularly characterized. Available
sequence information for the chicken genome (Board-ment for regions of the FcRY ectodomain in addition to
the CTLDs for binding to IgY (Figure 4A) demonstrates man et al., 2002) does not reveal obvious homologs of
FcRn (besides class I MHC proteins), but the recentthat ligand binding cannot be explained by a lectin activ-
ity of any single domain. identification of the chicken polymeric Ig receptor (pIgR)
(Wieland et al., 2004) and evidence of secretory compo-To gain insight into which domains of FcRY are in-
volved in FcY recognition, we constructed truncated nent in avian secretory IgA (Karaca and Naqi, 1997;
Peppard et al., 1986) implies that birds express a recep-forms of FcRY and tested their binding to FcY. We find
that two regions of FcRY, the CysR-FNII portion and tor that transports IgA into secretions. Hence, it appears
that the molecules responsible for the transcytosis ofthe CTLD1-8, do not individually bind IgY but form a
complex that binds IgY at acidic pH. By contrast, a large IgA are shared by birds and mammals, whereas this is
not the case for IgG/IgY. Instead, transcytosis of IgG inseries of PLA2R deletion constructs retained significant
ligand binding as long as CTLD5 was not removed (Nico- mammals and IgY in birds during passive acquisition
of maternal immunity by offspring is accomplished bylas et al., 1995), suggesting fundamentally different
modes of ligand recognition by FcRY and PLA2R. On fundamentally different types of proteins: a class I MHC-
related Fc receptor for IgG in mammals and a PLA2R-the basis of analytical ultracentrifugation and binding
studies, we propose that the more compact form of related Fc receptor for IgY in birds. The functional signifi-
cance of the relationship between the structures of FcRnFcRY observed at pH 6, in which the CysR-FNII domain
interacts with the CTLDs, is required for IgY binding and and MHC molecules in mammals and FcRY and PLA2R
in birds is unknown. However, the finding that birds dothat a conformational change at pH 8, which eliminates
the interaction between the CysR-FNII region and the not express an MHC-related Fc receptor that transfers
maternal antibodies to newborns but do express classCTLDs, results in a more elongated FcRY ectodomain
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Expression of Soluble FcRY and Deletion ConstructsI MHC molecules (Guillemot et al., 1989) suggests that
A construct encoding a soluble version of FcRY (including the nativethe peptide binding and T cell receptor recognition prop-
signal sequence and residues 1–1370 of the mature protein) with aerties of the MHC fold evolved prior to the immunoglobu-
C-terminal 6	-His tag was subcloned into the baculovirus transfer
lin binding and transport function. vector pVL1393 (Pharmingen, San Diego, CA). FcRY was purified
from supernatants of baculovirus-infected High 5 cells, exchanged
into 50 mM phosphate at pH 8.0, then subjected to Ni-NTA chroma-Experimental Procedures
tography (Ni-NTA Superflow, Qiagen). Protein from an imidazole
elution was further purified by gel filtration chromatography on aMaterials
Superdex 200 column. C-terminally His-tagged FcRY deletion con-Chicken IgY and porcine pancreatic PLA2 were purchased from
structs were prepared by PCR, and expression and purification wereSigma (St. Louis, MO). FcY and human IgG were purchased from
as for the full-length soluble fragment. The oligonucleotides (5
 toJackson ImmunoResearch Laboratories (West Grove, PA). Human
3
) used were: TCGAATTCTCAGTGATGATGATGATGATGGGTGTIgE was obtained from Scripps Laboratories (San Diego, CA). Re-
ATGTTTCTTGGAAAGGATGTTCAC for CysR alone (residues 1 tocombinant rat Fc was prepared as described in reference Martin
143 of mature protein), TCGAATTCTCAGTGATGATGATGATGATGand Bjorkman (1999).
CTCAACACCAGGACAAAAGCCCCATTTTTC for CysR-FNII (resi-
dues 1 to 197), TTTGCATATCCATTCACGCTTTTCATTGCAG and GAT
Affinity Purification of FcRY from Yolk Sac Membranes GCAGATCTTGATGCAGCAGAACC for CysR-FnII-CTLD1-4 (resi-
Yolk sacs were dissected from day 18–19 embryos, drained of yolk, dues 1 to 771), AAGGGAGGGCAGCTCGTCCCGGCTGA and GAA
and washed extensively in phosphate-buffered saline (PBS). Yolk AAATGGGGCTTTTGTCCTGGTGTT for CTLD1-8 (residues 187 to
sacs from eight to ten eggs were Dounce homogenized at 4C in 1370), and AGGACAAAAGCCCCATTTTTCATC and CCAAAAGGTG
PBS containing 3 mM EDTA and protease inhibitors (Complete TTAAACCAAAAAATCC for CysR-FNII-CTLD5-8 (residues 1 to 193
Mini, Roche, Indianapolis, IN). Homogenates were centrifuged at
and 773 to 1370).
100,000 	 g for 60 min. The pellet was solubilized by resuspension
in a binding buffer consisting of 0.15 M phosphate (pH 6.0), 60 mM
n-octyl -D-glucopyranoside, 10 mM D-gluconic acid lactone, 1 mM
Biosensor Assays
EDTA, and 0.02% NaN3. After 2 hr of stirring, the resuspended mate- A BIACORE 2000 biosensor system (Pharmacia, LKB Biotechnology)
rial was centrifuged again at 100,000 	 g for 30 min. The solubilized
was used to assay the interaction of FcRY with chicken IgY and Fc
membrane fraction was applied to an IgY affinity column (equili-
fragments. This system includes a biosensor chip with a dextran-
brated in binding buffer) prepared from CNBr-activated agarose
coated gold surface to which one protein (referred to as the “ligand”)
(Pharmacia, Uppsala, Sweden). After overnight incubation, the aga-
is covalently immobilized. Binding of an injected protein (the “ana-
rose beads were microfuged, and then washed three times in bind-
lyte”) to the immobilized protein results in changes of the surfaceing buffer and in diluted binding buffer (0.015 M phosphate [pH
plasmon resonance that are directly proportional to the amount of6.0], 30 mM n-octyl -D-glucopyranoside, 10 mM D-gluconic acid
bound protein and read out in real time as resonance units (RU)lactone, 1 mM EDTA, and 0.02% NaN3). Bound protein was eluted (Malmqvist, 1993).from pelleted beads by adding 150 l of the same buffer at a higher
FcRY was covalently immobilized to three of the four flow cellspH (0.15 M phosphate [pH 8.0]) and run on a 12% SDS-PAGE gel
on a CM5 biosensor chip (Pharmacia) using standard primary amineunder reducing conditions.
coupling chemistry (BIACORE manual) at three different densities
(500, 2400, and 7700 RU). The fourth flow cell was mock coupled
Peptide Sequencing using buffer to serve as a blank. IgY, FcY, and test proteins were
N-terminal sequencing yielded the sequence ALSRDELPSL, which injected at room temperature in 50 mM sodium phosphate (pH 6.0,
does not match any known proteins. To provide additional sequence pH 7.4, or pH 8.0), 150 mM NaCl, and 0.005% P20 surfactant. No
data, a proteolytic digestion was performed with Endo-Lys, and binding was observed at pH 6.0 for human IgG, human IgE, rat Fc,
individual peptides were isolated by HPLC. Three additional peptide or porcine pancreatic PLA2 at concentrations up to 5, 1, 10, and 10
sequences were assigned based on a combination of chemical se- M, respectively (data not shown). In other experiments, FcY or
quencing and mass spectroscopy. One of the internal peptide se- FcRY fragments were covalently immobilized to a flow cell using
quences (YVEDDSRNCGVFK) exactly matched two overlapping primary amine chemistry, and potential binding partners were in-
chicken ESTs (Boardman et al., 2002) (clone IDs ChEST872p24 jected over the chip surface. The binding data were analyzed using
and ChEST724b16). the programs BIAevaluation v3.1 (Biacore AB) and Clamp99 (Morton
and Myszka, 1998). In the case of FcY injections over coupled FcRY,
binding reactions were allowed to reach or closely approach equilib-Cloning of FcRY by RACE-PCR
rium, and KDs were derived by nonlinear regression analysis of plotsmRNA was prepared from freshly dissected yolk sac membranes
of Req (the equilibrium binding response) versus the analyte concen-using the RNeasy kit (Qiagen, Chatsworth, CA). Primers were initi-
tration (Figure 3A). For FcRY injections over coupled FcY, kinetically designed to amplify a 415 bp fragment contained in EST
constants were derived from sensorgram data using simultaneousChEST872p24. RACE-PCR was used to obtain the full-length mes-
fitting to the association and dissociation phases of the interactionsage (SMART RACE-PCR kit, Clontech, Palo Alto, CA; Gene-Racer
and global fitting to all curves in the working set (Figure 3B).Kit, Invitrogen, Carlsbad, CA). Partial clones missing the 5
 end were
Since each polypeptide chain of an FcY homodimer can be boundobtained initially, and these were used to design new primers to
by an FcRY molecule, the binding data were analyzed using modelsobtain the entire coding region.
assuming sequential binding of FcRY to the first and second binding
sites on an FcY homodimer. Thus, reactions involving FcY as the
RNA Blot Analysis injected protein (analyte) (Figure 3A) were analyzed using the biva-
A Northern blot (RNway Laboratories, Seoul, Korea) was hybridized lent analyte model described previously (West and Bjorkman, 2000),
with a 32P-dATP-labeled probe consisting of a 695 bp PCR product and reactions involving FcY as the immobilized protein (ligand) (Fig-
(Strip-EZ PCR kit, Ambion, Austin, TX) corresponding to the 5
 region ure 3B) were analyzed using the bivalent ligand model using
of the FcRY cDNA. Clamp99. Simple 1:1 binding models did not account for the ob-
served data as judged from large residuals in the fits (data not
shown). We also fit the binding data to a heterogeneous ligandExpression of FcRY
model involving two classes of noninteracting binding sites as de-Full-length FcRY (in vector pcDNA3.1) was transfected into CHO
scribed for the analysis of rat FcRn with IgG (Vaughn and Bjorkman,cells using Lipofectamine 2000 (Invitrogen). Two days after transfec-
1997). This model derives macroscopic equilibrium dissociationtion, cells were washed with a pH 6.0 buffer, incubated on ice with
constants and the percentage of the total response due to each500 nM Cy3-labeled FcY (Jackson Immunoresearch) for 30 min, and
then washed. class of binding site on the biosensor chip.
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A.B.H.), a career research award from the Burroughs-WellcomeThe column was eluted with 10 mM Tris, 10 mM bis-Tris, 150 mM
NaCl at pH 6.0, or 20 mM Tris, 150 mM NaCl at pH 8.0. FcRY samples Fund (A.P.W.), the NIH (2 R01 AI041239-06A1 to P.J.B.), and the
Howard Hughes Medical Institute (P.J.B.).(150 l) were injected at concentrations of 80 and 800 nM. Elution
profiles did not change over this concentration range.
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